Kinsey Caldwell Named Access Innovator in the 2026 PM360 Magazine ELITE 100
We’re thrilled to share that SVP Kinsey Caldwell has been named Access Innovator in the 2026 PM360 Magazine ELITE 100!
Kinsey led the development of GENEROUS Navigator, a first-of-its-kind, two-tiered solution designed to bring clarity and actionability to a fragmented landscape. Through GENEROUS Navigator, Kinsey is not just helping manufacturers manage complexity, she is advancing a more transparent, efficient, and equitable access environment for patients nationwide.
Each year, the PM360 ELITE Awards recognize the most influential leaders, innovators, and changemakers across the healthcare and life sciences industries. This year’s honorees represent the very best in creativity, leadership, collaboration, and innovation—driving meaningful impact across the industry and improving outcomes for patients everywhere.
Kinsey stands out as a true Access Innovator, redefining how pharmaceutical manufacturers approach one of the industry’s most complex challenges: navigating the CMS GENEROUS Model. With a clear understanding of the tension between pricing strategy, patient access, and competitive risk, Kinsey identified a critical gap early: manufacturers lacked both visibility into evolving state-level coverage requirements and the strategic tools needed to respond effectively.
In response, Kinsey led the development of GENEROUS Navigator, a first-of-its-kind, two-tiered solution designed to bring clarity and actionability to a fragmented landscape. At its core, the platform aggregates nationwide data on prior authorization criteria and preferred drug list placement, transforming disparate and often inaccessible information into a standardized, CMS-ready format. This foundational capability alone significantly improves transparency and operational efficiency across organizations.
What distinguishes Kinsey’s leadership is the emphasis on moving beyond insight generation to strategic execution. Through the Strategic Coverage + Analytics offering, her team integrates global pricing benchmarks, predictive rebate modeling, and competitive scenario planning. This allows manufacturers to evaluate the real-world implications of participating in the GENEROUS Model and make informed, high-stakes decisions that directly influence both access and affordability for patients.
Kinsey’s collaborative, cross-functional approach has also been essential in addressing industry-wide challenges, including shifting CMS guidance and variability in Medicaid policies across states. By aligning expertise across evidence, pricing, and policy, she has helped build a forward-looking solution that not only meets current regulatory demands but anticipates future market dynamics. Through GENEROUS Navigator, Kinsey is not just helping manufacturers manage complexity, she is advancing a more transparent, efficient, and equitable access environment for patients nationwide.
Reach out to us to learn more about GENEROUS Navigator.
About the Author
Kinsey Caldwell Named Access Innovator in the 2026 PM360 Magazine ELITE 100
We’re thrilled to share that SVP Kinsey Caldwell has been named Access Innovator in the 2026 PM360 Magazine ELITE 100.
Join Us for the Virtual Advantage+ Medicaid Policy Summit
A one-day virtual event focused exclusively on the evolving Medicaid policy and drug pricing landscape.
Demystifying Most Favored Nation Innovation Models
MFN pricing is here, expanding, and increasingly complex. CMS is advancing multiple Innovation Center models that tie U.S. drug prices to international benchmarks across Medicaid and Medicare with implications for rebates, strategy, and market access.